Aberdeen Group
OGN icon

Aberdeen Group’s Organon & Co OGN Stock Holding History

Aberdeen Group’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-19,434
Closed -$337K – 976
2023
Q3 		$337K Sell
19,434
-42,361
-69% -$883K ﹤0.01% 847
2023
Q2 		$1.29M Sell
61,795
-859
-1% -$18.7K ﹤0.01% 770
2023
Q1 		$1.47M Sell
62,654
-65
-0.1% -$1.75K ﹤0.01% 758
2022
Q4 		$1.75M Buy
62,719
+3,840
+7% +$98.2K ﹤0.01% 719
2022
Q3 		$1.38M Buy
58,879
+928
+2% +$28K ﹤0.01% 750
2022
Q2 		$1.99M Sell
57,951
-2,264
-4% -$79.3K 0.01% 710
2022
Q1 		$2.14M Sell
60,215
-42,315
-41% -$1.45M 0.01% 731
2021
Q4 		$3.12M Sell
102,530
-4,431
-4% -$144K 0.01% 719
2021
Q3 		$3.55M Sell
106,961
-3,464
-3% -$111K 0.01% 708
2021
Q2 		$3.34M Buy
+110,425
New +$3.63M 0.01% 703

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Aberdeen Group's OGN Position: Q4 2023 in Review

Aberdeen Group sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 19,434 shares — an estimated $337K sold.

Aberdeen Group first reported a position in OGN in Q2 2021 and held it in 10 quarters. The position peaked at $3.55M in Q3 2021. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • Aberdeen Group reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • Aberdeen Group sold 19,434 Organon & Co shares in Q4 2023, an estimated $337K.
  • Aberdeen Group first reported a position in Organon & Co in Q2 2021 and held it in 10 quarters.
  • Aberdeen Group's Organon & Co position peaked at $3.55M in Q3 2021.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Aberdeen Group's 13F filing for Q4 2023, filed 31 Jan 2024.